ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

University of Gothenburg at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

University of Gothenburg takes part in 3 sessions at ESMO 2026 in Madrid. Its work spans melanoma and colorectal cancer, including surgery and biomarkers. It examines whether ultraviolet-related mutations can help predict outcomes in melanoma and how tumor stage relates to colon cancer patients’ perceptions of cure.

OrganizationESMO 2026 Attendance
University of Gothenburg
Gothenburg, Sweden
University & institute
Public university in Gothenburg, Sweden, whose health sciences faculty includes a medical school.
Poster
Fri Oct 23
13:00–15:00
UV-mutational signal metrics as a prognostic biomarker in cutaneous melanoma
ePoster session 11
Melanoma & skin cancersBiomarkers & precision oncology
Chair
Sat Oct 24
14:45–16:15
Cutting edge: The evolving role of surgeons in melanoma
with University Medical Center Utrecht
Melanoma & skin cancers
Talk
Sat Oct 24
14:45–15:10
Neoadjuvant therapy and the changing role of surgery in melanoma
Cutting edge: The evolving role of surgeons in melanoma
Melanoma & skin cancers
Poster
Sun Oct 25
12:00–12:45
Tumour stage does not affect perception of cure in patients with colon cancer
Sunday Poster Display session 5
Gastrointestinal cancersNursing & supportive care

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Gothenburg

Tell us what you sell and we’ll find the people at University of Gothenburg most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction